Argenx news shop
Argenx news shop
Argenx news shop
Argenx news shop
Argenx news shop
Argenx news shop

Argenx news shop

Argenx news shop, Subcutaneous version of argenx s Vvygart fails key ITP study shop

$55.00

SKU: 6741129

Colour
  • FDA approval of Argenx neuromuscular disease therapy is first in
  • US FDA accepts argenx s VYVGART Hytrulo for CIDP review
  • argenx on X
  • Drugmakers Circle 23 Billion Biotech Argenx Ahead of Key Data
Out of stock
Personalised:
: ( x )
Personalisation:
Edit
Remove Personalisation
Frasers Plus

Buy now.

Pay later.

Earn rewards

Representative APR: 29.9% (variable)

Credit subject to status. Terms apply.

Missed payments may affect your credit score

FrasersPlus